GID BIO Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $5.34M

  • Investors
  • 3

GID BIO General Information

Description

Developer of cellular therapies technology intended to enable cell-based treatments for osteoarthritis of the knee and other diseases. The company's technology harvests and isolates a patient's stromal and vascular cells, including stromal progenitor cells, to help control pain, reduce inflammation, and repair inflamed tissues, enabling healthcare providers to offer patients a walk-in and walk-out procedure for tissue harvest and cellular implant.

Contact Information

Website
www.gidbio.com
Formerly Known As
The GID Group, GID Group
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 901 Front Street
  • Suite 240
  • Louisville, CO 80027
  • United States
+1 (303)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 901 Front Street
  • Suite 240
  • Louisville, CO 80027
  • United States
+1 (303)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GID BIO Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 30-Dec-2021 $5.34M Completed Generating Revenue
5. Grant 18-Aug-2020 Completed Generating Revenue
4. Later Stage VC 20-Jan-2020 Completed Generating Revenue
3. Later Stage VC (Series C) 10-Jan-2014 Completed Generating Revenue
2. Early Stage VC (Series B) 01-Dec-2011 $2.66M $5.16M Completed Generating Revenue
1. Early Stage VC (Series A) 19-May-2010 $2.5M $2.5M Completed Generating Revenue
To view GID BIO’s complete valuation and funding history, request access »

GID BIO Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C
Series B
Series A 325,000 $0.001000 $8.9 $8.9 1x $8.9 26.85%
To view GID BIO’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

GID BIO Patents

GID BIO Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230332094-A1 Adipose tisssue processing method Active 18-Jul-2017
EP-3655518-A1 Adipose tissue digestion system and tissue processing method Pending 18-Jul-2017
EP-3655518-A4 Adipose tissue digestion system and tissue processing method Pending 18-Jul-2017
US-11732233-B2 Adipose tissue digestion system and tissue processing method Active 18-Jul-2017
US-20200181561-A1 Adipose tissue digestion system and tissue processing method Active 18-Jul-2017 C12M45/09
To view GID BIO’s complete patent history, request access »

GID BIO Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

GID BIO Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Richard King Mellon Foundation Limited Partner
Ithaka Partners Growth/Expansion Minority
Eagles Ketch Asset Manager Minority
To view GID BIO’s complete investors history, request access »

GID BIO FAQs

  • When was GID BIO founded?

    GID BIO was founded in 2008.

  • Where is GID BIO headquartered?

    GID BIO is headquartered in Louisville, CO.

  • What is the size of GID BIO?

    GID BIO has 8 total employees.

  • What industry is GID BIO in?

    GID BIO’s primary industry is Drug Discovery.

  • Is GID BIO a private or public company?

    GID BIO is a Private company.

  • What is GID BIO’s current revenue?

    The current revenue for GID BIO is .

  • How much funding has GID BIO raised over time?

    GID BIO has raised $35.2M.

  • Who are GID BIO’s investors?

    Richard King Mellon Foundation, Ithaka Partners, and Eagles Ketch have invested in GID BIO.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process